文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

妊娠非酒精性脂肪性肝病与不良的母儿围生结局相关。

Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.

机构信息

Division of GI/Hepatology, University of California, San Francisco, San Francisco, CA, USA.

Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.

出版信息

J Hepatol. 2020 Sep;73(3):516-522. doi: 10.1016/j.jhep.2020.03.049. Epub 2020 Jun 9.


DOI:10.1016/j.jhep.2020.03.049
PMID:32531415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438303/
Abstract

BACKGROUND & AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear. METHODS: Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension. RESULTS: Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7-8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3-5% vs. 6%), and preterm birth (5-7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death. CONCLUSION: The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care. LAY SUMMARY: The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.

摘要

背景与目的:非酒精性脂肪性肝病(NAFLD)在年轻成年人中的发病率正在上升,这可能对生育年龄的妇女产生影响。妊娠期间的 NAFLD 是否会对产妇或围产期健康造成更严重的风险尚不清楚。

方法:我们利用美国国家住院患者样本的加权出院数据,评估了妊娠 20 周后 NAFLD 的时间趋势,并将其结果与其他慢性肝病(CLD)或无 CLD 的妊娠进行了比较。研究结果包括早产、产后出血、高血压并发症(子痫前期、子痫和/或溶血、肝酶升高和血小板减少症)以及产妇或胎儿死亡。通过日历年来估计 NAFLD 的患病率,并通过线性回归来检验时间趋势。通过逻辑回归分析对年龄、种族、多胎妊娠以及孕前糖尿病、肥胖、血脂异常和高血压进行调整,对结果进行分析。

结果:在 18574225 例妊娠中,5640 例有 NAFLD,115210 例有其他非 NAFLD 的 CLD。NAFLD 妊娠的比例从 2007 年的 10.5/100000 例增加到 2015 年的 28.9/100000 例,几乎增加了两倍(p<0.001)。与其他组相比,妊娠期间患有 NAFLD 的患者更常发生妊娠期糖尿病(7-8% vs. 23%)、高血压并发症(4% vs. 16%)、产后出血(3-5% vs. 6%)和早产(5-7% vs. 9%),所有 p 值均≤0.01。在调整分析中,与无 CLD 相比,NAFLD 与高血压并发症、早产、产后出血和可能的产妇(而非胎儿)死亡相关。

结论:在过去十年中,妊娠中 NAFLD 的患病率几乎增加了两倍,与高血压并发症、早产和产后出血独立相关。NAFLD 应被视为一种高危产科情况,对孕前咨询和妊娠护理具有临床意义。

非医学背景的普通人理解起来可能会有一些困难,如果你有任何问题,请随时提问。

相似文献

[1]
Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.

J Hepatol. 2020-9

[2]
Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.

Am J Gastroenterol. 2022-3-1

[3]
Outcomes of pregnancy in autoimmune hepatitis: A population-based study.

Hepatology. 2022-1

[4]
Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.

Liver Int. 2016-2

[5]
The role of maternal age on adverse pregnancy outcomes among primiparous women with singleton birth: a retrospective cohort study in urban areas of China.

J Matern Fetal Neonatal Med. 2023-12

[6]
Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.

PLoS One. 2019-4-12

[7]
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.

PLoS Med. 2021-11

[8]
Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.

Am J Obstet Gynecol. 2021-11

[9]
Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension.

Am J Obstet Gynecol. 2021-5

[10]
Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis.

Hum Reprod. 2018-10-1

引用本文的文献

[1]
Global, regional, and national time trends in prevalence of metabolic dysfunction associated steatotic liver disease among women of reproductive age: an age-period-cohort analysis for the global Burden of Disease 2021 study.

Ann Med. 2025-12

[2]
Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15-49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study.

Front Med (Lausanne). 2025-6-25

[3]
Adverse pregnancy and birth outcomes in women with biopsy-proven MASLD: a nationwide cohort study.

EClinicalMedicine. 2025-5-9

[4]
Associations of hepatic steatosis index in early pregnancy with perinatal outcomes: A prospective birth cohort study.

Clin Med (Lond). 2025-7

[5]
Global burden of metabolic-associated fatty liver disease among women of childbearing age: Trends from 1990 to 2021 and projections to 2040.

PLoS One. 2025-6-17

[6]
[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes].

Beijing Da Xue Xue Bao Yi Xue Ban. 2025-6-18

[7]
Mortality and Cancer in Offspring of Mothers With Biopsy-Proven MASLD During Pregnancy: A Nationwide Cohort Study.

Liver Int. 2025-7

[8]
Challenges in applying MASLD risk algorithms in pregnancy: A call for adaptation and inclusion.

J Hepatol. 2025-5-28

[9]
The Maternal and Fetal Consequences of Metabolic Dysfunction-Associated Fatty Liver Disease and Gestational Diabetes Mellitus.

Nutrients. 2025-5-20

[10]
Metabolic dysfunction-associated steatotic liver disease and pregnancy.

J Clin Invest. 2025-5-15

本文引用的文献

[1]
Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.

PLoS One. 2019-8-26

[2]
Gestational diabetes mellitus.

Nat Rev Dis Primers. 2019-7-11

[3]
Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.

PLoS One. 2019-4-12

[4]
Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Nat Rev Nephrol. 2019-5

[5]
Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.

Diabetologia. 2018-11-23

[6]
Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

Liver Int. 2018-9-25

[7]
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Clin Gastroenterol Hepatol. 2018-6-14

[8]
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.

Am J Gastroenterol. 2018-6-8

[9]
Adherence to Methodological Standards in Research Using the National Inpatient Sample.

JAMA. 2017-11-28

[10]
Epidemiology of cardiovascular disease in young individuals.

Nat Rev Cardiol. 2017-10-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索